Kalocyte Inc.
Baltimore, MD
- UEI
- MJMKM31FM667
- CAGE
- 7KNT0
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 4 N Martin Luther King Jr Blvd fl 3, Baltimore, MD 21201, USA
- Website
- kalocyte.com
- Founded
- 2016
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Production of GLP erythromer for IND enabling animal studies | Defense Advanced Research Projects Agency | $1,799,993 | |
| Optimized lyophilization and reconstitution of erythromer, a BIO-inspired, artificial red blood cell | Defense Health Agency | $2,461,670 | |
| Rapid reconstitution of a lyophilized, BIO-inspired, artificial red blood cell | National Heart Lung and Blood Institute | $373,216 | |
| Erythromer: nanoscale biosynthetic red cell substitute - research summary/abstract erythromer (EM) is a novel… | National Heart Lung and Blood Institute | $6,088,240 | |
| Manufacturing scale-up, purification, and analytical method development, validation and qualification for KC1003, key… | National Heart Lung and Blood Institute | $1,999,996 |
About Kalocyte Inc.
Kalocyte Inc., a self-certified small disadvantaged biotech company based in Baltimore, Maryland, develops bio-inspired artificial red blood cell substitutes (ErythroMer) for military and civilian trauma resuscitation, competing as a prime contractor (86% of recent awards) and subcontractor on federal R&D programs under full-and-open competitive set-asides with no set-aside restriction.
Kalocyte's capability portfolio centers on the design, development, and manufacturing of ErythroMer, a synthetic oxygen-carrying fluid engineered to address hemorrhagic shock in trauma scenarios. The company operates across the full lifecycle from early research through GLP-compliant manufacturing for regulatory submissions. Recent prime work includes a $1.8 million Other Transaction Agreement awarded by the Defense Advanced Research Projects Agency in August 2025 for production of GLP-grade ErythroMer to support Investigational New Drug animal studies, with performance extending through August 2026 in Baltimore; and a multi-year federal grant from the Defense Health Agency (award date April 2024, completion date April 2027) for optimized lyophilization and reconstitution of ErythroMer, extended by twelve months. Kalocyte subcontracts to the CONCERT (Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy) consortium under Phase 1 base and incremental funding for whole blood analogue pre-clinical development and IND submission support.
Customer concentration splits between the National Institutes of Health National Heart Lung and Blood Institute (four awards, a 57% share of awards), the Defense Advanced Research Projects Agency (two awards, $1.8 million combined potential value), and the Defense Health Agency (one award). The vendor maintains university partnerships with the University of Illinois at Urbana-Champaign for manufacturing and Washington University in St. Louis for in vivo efficacy validation. Three awards totaling $1.8 million in combined potential value reach ultimate completion within the next twenty-four months, representing the recompete window for these programs.
Quick answers
What is Kalocyte Inc.'s UEI?
Kalocyte Inc.'s Unique Entity ID (UEI) in SAM.gov is MJMKM31FM667.
What is Kalocyte Inc.'s CAGE code?
Kalocyte Inc.'s CAGE code is 7KNT0.
What is Kalocyte Inc.'s primary NAICS code?
Kalocyte Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).
Where is Kalocyte Inc. located?
Kalocyte Inc.'s physical address in SAM.gov is 4 N Martin Luther King Jr Blvd fl 3, Baltimore, MD 21201, USA.
Is Kalocyte Inc. registered in SAM.gov?
Yes. Kalocyte Inc.'s SAM.gov registration is active through March 19, 2027.
What is Kalocyte Inc.'s most recent federal award?
Kalocyte Inc.'s most recent federal contract award is Production of GLP erythromer for IND enabling animal studies (HR00112590241), from Defense Advanced Research Projects Agency, on August 14, 2025.
On GovTribe
See Kalocyte Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors